Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Rocilinostat
Potential treatment - theoretical effect Experimental Other treatment May/17/2020
OTX015
Potential treatment - theoretical effect Experimental Other treatment May/17/2020
Panobinostat
Potential treatment - theoretical effect Experimental Other treatment May/17/2020
Resminostat
Potential treatment - theoretical effect Experimental Other treatment May/17/2020
PI-103
Potential treatment - theoretical effect Experimental Other treatment May/17/2020
UCN-01
Potential treatment - theoretical effect Experimental Other treatment May/17/2020
LY2835219
Potential treatment - theoretical effect Experimental Other treatment May/17/2020
ENMD-2076
Potential treatment - theoretical effect Experimental Other treatment May/17/2020
PI3KA Inhibitor IV
Potential treatment - theoretical effect Experimental Other treatment May/17/2020
CC-223
Potential treatment - theoretical effect Experimental Other treatment May/17/2020
PF-04691502
Potential treatment - theoretical effect Experimental Other treatment May/17/2020
TAK-733
Potential treatment - theoretical effect Experimental Other treatment May/17/2020
Refametinib
Potential treatment - theoretical effect Experimental Other treatment May/17/2020
Binimetinib
Potential treatment - theoretical effect Experimental Other treatment May/17/2020
PD0325901
Potential treatment - theoretical effect Experimental Other treatment May/17/2020
TAE684
Potential treatment - theoretical effect Experimental Other treatment May/17/2020
Dovitinib
Potential treatment - theoretical effect Experimental Other treatment May/17/2020
Ki8751
Potential treatment - theoretical effect Experimental Other treatment May/17/2020
ShaCoVacc
Potential treatment - pre-clinical evidence Experimental Vaccine May/15/2020
VHH-72-VHH-72
Potential treatment - pre-clinical evidence Experimental Antiviral May/05/2020